Signals for Fingolimod (GILENYA) and Infliximab (REMICADE). Institute for Safe Medication Practices QuarterWatch: monitoring FDA MedWatch reports. 2012 - Moore, T J; Cohen, M R; Furberg, C D
. Accessed April 12, 2012.